Withdrawal: Makena
Apr. 2023Pharmacy Updates
On March 7, 2023, Covis Pharma announced that it is withdrawing Makena (hydroxyprogesterone caproate injection; also referred to as 17-OHPC) from the market. This drug is used to reduce the risk of preterm birth in women who are pregnant with one baby and have a history of spontaneous preterm birth. Read more about the Makena withdrawal.
Recent Announcements
Voluntary nationwide recall: Lactated Ringers and 0.9% Sodium Chloride (B. Braun-Aug)
B. Braun Medical, Inc. is recalling two lots of Lactated Ringers Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL. These are intravenous (IV) fluids commonly used in the hospital to treat dehydration and other conditions.Aug. 2025Pharmacy Updates
CME Webinar: Evaluating Antimicrobial Stewardship Techniques in the Outpatient Setting
Please join us for a live, CME-accredited webinar on Tuesday, Nov. 4, from noon to 1 p.m. that will share an overview of evaluating antimicrobial stewardship techniques in the outpatient setting.Aug. 2025Education/Webinars
Understanding available resources for substance misuse and addiction
Information available on the internet can be overwhelming when searching on the topic of substance misuse and addiction. UPMC Health Plan has a dedicated webpage containing information and links to treatment service options, harm reduction services, and other supports. The webpage includes local, state, and national resources to help streamline the search process for members and their families who may be experiencing challenges related to substance misuse and addiction, and for providers who may be looking for information on how to best support their patients.Aug. 2025Important Notices